Innovita Biological Technology Co., Ltd. (SHA:688253)

SHA:688253 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	369.25	567.09	307.73	166.46	388.67	479.74
Trading Asset Securities	1,410	1,382	1,584	1,531	1,115	87.25
Cash & Short-Term Investments	1,779	1,949	1,892	1,697	1,503	566.99
Cash Growth	-3.76%	3.03%	11.49%	12.89%	165.14%	-4.92%
Accounts Receivable	9.03	12	37.83	105.17	124.31	4.13
Other Receivables	4.6	1.85	1.95	1.68	10.63	0.27
Receivables	13.63	13.85	39.78	106.86	134.95	4.4
Inventory	46.7	57.18	43.47	61.51	74.8	43.63
Other Current Assets	5.26	6.77	22.21	7.2	24.46	32.81
Total Current Assets	1,845	2,027	1,998	1,873	1,738	647.83
Property, Plant & Equipment	114.99	128.88	120.21	118.39	130.29	116.93
Long-Term Investments	138.95	57.89	35.65	34.26	14.94	5
Goodwill	3.64	3.64	-	-	-	-
Other Intangible Assets	18.7	18.32	6.79	7.02	7.25	7.49
Long-Term Deferred Tax Assets	26	24.84	22.65	13.41	2.26	1.22
Long-Term Deferred Charges	8.38	7.98	11.19	8.65	12.02	7.31
Other Long-Term Assets	2.7	6.69	18.42	11.31	38.3	12.1
Total Assets	2,158	2,275	2,212	2,066	1,943	797.87

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	41.25	79.12	90.93	63.57	71.56	21.16
Accrued Expenses	14.87	26.74	41.94	25.37	27.44	20.31
Short-Term Debt	-	-	-	-	17.62	-
Current Portion of Leases	-	3.84	3.2	1.96	3.01	0.88
Current Income Taxes Payable	5.02	0.92	0.95	16.34	4.31	2.64
Current Unearned Revenue	9.36	83.43	57.25	100.66	105.1	5.9
Other Current Liabilities	11.05	19.56	15.94	7.34	14.06	1.27
Total Current Liabilities	86.02	213.6	210.21	215.23	243.11	52.15
Long-Term Leases	2.38	3.95	2.57	1.04	2.49	0.52
Long-Term Unearned Revenue	1.52	1.91	3.14	4.8	6.33	6.99
Long-Term Deferred Tax Liabilities	4.2	3.86	3.15	2.58	1.31	0.05
Total Liabilities	94.12	223.32	219.07	223.65	253.24	59.7

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	137.97	136.98	136.46	136.06	136.06	102.04
Additional Paid-In Capital	1,080	1,053	1,036	1,024	1,022	255.67
Retained Earnings	924.87	944.18	874.94	682.51	531.15	380.46
Treasury Stock	-78.01	-78.01	-50.01	-	-	-
Comprehensive Income & Other	-0.31	-4.18	-3.65	-1.02	-	-
Total Common Equity	2,064	2,052	1,993	1,842	1,689	738.17
Shareholders' Equity	2,064	2,052	1,993	1,842	1,689	738.17
Total Liabilities & Equity	2,158	2,275	2,212	2,066	1,943	797.87

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	6.84	7.78	5.77	3	23.12	1.4
Net Cash (Debt)	1,772	1,942	1,886	1,694	1,480	565.59
Net Cash Growth	-3.87%	2.93%	11.35%	14.45%	161.71%	-3.73%
Net Cash Per Share	12.91	14.25	13.83	12.47	12.18	5.55
Filing Date Shares Outstanding	143.25	134.87	134.87	136.06	136.06	102.04
Total Common Shares Outstanding	143.25	134.87	134.87	136.06	136.06	102.04
Working Capital	1,759	1,814	1,787	1,657	1,494	595.68
Book Value Per Share	14.41	15.21	14.78	13.54	12.42	7.23
Tangible Book Value	2,042	2,030	1,987	1,835	1,682	730.68
Tangible Book Value Per Share	14.25	15.05	14.73	13.49	12.36	7.16
Buildings	-	105.12	97.96	97.96	94.67	85.39
Machinery	-	112.92	98.21	86.21	77.17	61.21
Construction In Progress	-	3.68	2.37	-	-	0.2

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error